Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular profiles of high-grade and low-grade pseudomyxoma peritonei.

Cancer medicine - 1 Dec 2015

Noguchi Rei, Yano Hideaki, Gohda Yoshimasa, Suda Ryuichiro, Igari Toru, Ohta Yasunori, Yamashita Naohide, Yamaguchi Kiyoshi, Terakado Yumi, Ikenoue Tsuneo, Furukawa Yoichi

Abstract excerpt

Pseudomyxoma peritonei (PMP) is a rare disease exhibiting a distinct clinical feature caused by cancerous cells that produce mucinous fluid in the abdominal cavity. PMPs originate most frequently from the appendix and less frequently from the ovary. This disease can range from benign to malignant, and histologically, PMP is classified into two types: disseminated peritoneal adenomucinosis (DPAM) representing the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Combined Modality Therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Expression Profiling

Share to Immunohistochemistry

Share to Neoplasm Grading

Share to Peritoneal Neoplasms

Share to Transcriptome

Share to Tumor Suppressor Protein p53

Source

Open in PubMed Open full text

Identifiers

PMID: 26475379
DOI: 10.1002/cam4.542
PMCID: PMC5123786

Genes

GNAS
KRAS
AKT1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular profiles of high-grade and low-grade pseudomyxoma peritonei.PMID 26475379Read ↗

Genomic profile of pseudomyxoma peritonei analyzed using next-generation sequencing and immunohistochemistry.Semantic proximity Read ↗

Appendix-derived Pseudomyxoma Peritonei (PMP): Molecular Profiling Toward Treatment of a Rare Malignancy.Semantic proximity Read ↗

Targeted Genetic Sequencing Analysis of 223 Cases of Pseudomyxoma Peritonei Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Shows Survival Related to GNAS and KRAS Status.Semantic proximity Read ↗

The mutational landscape and prognostic indicators of pseudomyxoma peritonei originating from the ovary.Semantic proximity Read ↗

Whole-Exome Sequencing Identifies Mutation Profile and Mutation Signature-Based Clustering Associated with Prognosis in Appendiceal Pseudomyxoma Peritonei.Semantic proximity Read ↗

Multiple components of PKA and TGF-β pathways are mutated in pseudomyxoma peritonei.Semantic proximity Read ↗

The biological basis and function of GNAS mutation in pseudomyxoma peritonei: a review.Semantic proximity Read ↗

Rare Occurrence of Pseudomyxoma Peritonei (PMP) Syndrome Arising from a Malignant Transformed Ovarian Primary Mature Cystic Teratoma Treated by Cytoreductive Surgery and HIPEC: A Case ReportSemantic proximity Read ↗

Molecular Profiling of Low-Grade Appendiceal Mucinous Neoplasms (LAMN).Semantic proximity Read ↗

Distinct cell states define the developmental trajectories of mucinous appendiceal neoplasms towards pseudomyxoma metastasesSemantic proximity Read ↗

Pathological prognostic factors of pseudomyxoma peritonei: comprehensive clinicopathological analysis of 155 cases.Semantic proximity Read ↗

Progress on immuno-microenvironment and immune-related therapies in patients with pseudomyxoma peritonei.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.